Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Approves Rituxan for First-Line Maintenance Use in Follicular Lymphoma
FDA Approves Rituxan for First-Line Maintenance Use in Follicular Lymphoma
FDA Approves Rituxan for First-Line Maintenance Use in Follicular Lymphoma
Submitted by
admin
on January 29, 2011 - 11:24am
Source:
BusinessWire
News Tags:
Roche Group
Biogen Idec
follicular lymphoma
Rituxan
Headline:
FDA Approves Rituxan for First-Line Maintenance Use in Follicular Lymphoma
Do Not Allow Advertisers to Use My Personal information
